[ad_1]
The Johnson & Johnson group earned $ 8,321 million in the first half of this year, up 0.9% from the same period last year, thanks to a sharp rise in revenue from its pharmaceutical business.
the US company reported net income of $ 3.05 compared to $ 3.00 in the first six months of 2017.
If a series of one-time charges in the accounts of the last months are updated, Johnson & Johnson reportedly earned $ 11,353 The New Brunswick-based company's sales reached $ 40,839 million in the first half, an increase of 11.6%.
In the second quarter, Johnson & Johnson realized a net profit of $ 3,954 million, or 3.3% more than the same months of the previous year.
Earnings at $ 20,830 million, up 10.6%
"Our strong second quarter results reflect double-digit growth in our pharmaceuticals business Sales acceleration in our medical equipment business, "said Alex Gorsky, CEO, in a statement. 19659002] The accounts, better than expected by analysts, yesterday triggered the company's stock.
Source link
